Other intangible assets—net
Pfizer Other intangible assets—net decreased by 2.2% to $52.56B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.6%, from $53.98B to $52.56B. Over 5 years (FY 2020 to FY 2025), Other intangible assets—net shows an upward trend with a 13.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase typically signals recent strategic acquisitions or significant investment in R&D and intellectual property, while a decrease reflects ongoing amortization or potential impairment.
Detailed definition
This represents the net book value of identifiable non-physical assets such as patents, intellectual property, software...
Peer comparison
High in semiconductor and tech firms due to heavy reliance on patent portfolios and acquired technology.
non_current_assets_intangible_assets_net_excluding_goodwillHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $27.32B | $26.31B | $25.15B | $29.82B | $29.07B | $28.15B | $43.37B | $42.00B | $41.41B | $40.22B | $64.90B | $62.83B | $61.24B | $59.99B | $55.41B | $53.98B | $52.70B | $51.32B | $53.73B | $52.56B |
| QoQ Change | — | -3.7% | -4.4% | +18.6% | -2.5% | -3.1% | +54.1% | -3.2% | -1.4% | -2.9% | +61.3% | -3.2% | -2.5% | -2.0% | -7.6% | -2.6% | -2.4% | -2.6% | +4.7% | -2.2% |
| YoY Change | — | — | — | — | +6.4% | +7.0% | +72.5% | +40.9% | +42.5% | +42.9% | +49.6% | +49.6% | +47.9% | +49.1% | -14.6% | -14.1% | -13.9% | -14.4% | -3.0% | -2.6% |
Other intangible assets—net at Other Companies
Frequently Asked Questions
- What is Pfizer's other intangible assets—net?
- Pfizer (PFE) reported other intangible assets—net of $52.56B in Q1 2026.
- How has Pfizer's other intangible assets—net changed year-over-year?
- Pfizer's other intangible assets—net decreased by 2.6% year-over-year, from $53.98B to $52.56B.
- What is the long-term trend for Pfizer's other intangible assets—net?
- Over 5 years (2020 to 2025), Pfizer's other intangible assets—net has grown at a 13.7% compound annual growth rate (CAGR), from $28.34B to $53.73B.
- What does other intangible assets—net mean?
- The value of non-physical assets like patents and intellectual property, excluding goodwill.